Koronavirüs 2019 Geçirmiş Vertigosu Olan ve Olmayan Hastaların Subjektif Değerlendirilmesi

Yıl 2022, Cilt: 10 Sayı: 2, 521 - 529, 20.06.2022

Tuğba Emekci Fatmanur Uysal Serpil Demir Mehmet Dündar

https://doi.org/10.33715/inonusaglik.1010406

Öz

Bu çalışmanın amacı; COVID 19 geçirmiş, vertigosu olan ve olmayan bireylerin psikolojik, emosyonel, uyku kalitesi ve düşme ihtimaline yönelik endişeleri açısından karşılaştırılmasıdır. Araştırmaya, COVID 19 geçirmiş vertigo tanısı almış 15 denek vaka grubu ve COVID 19 geçirmiş vertigo tanısı almamış 15 denek kontrol grubu olmak üzere 30 birey dâhil edildi. Araştırmaya dahil edilen bireylere, Uluslararası Düşme Etkinliği Ölçeği (Falls Efficacy Scale International- FES -I), Hastane Anksiyete ve Depresyon Ölçeği (Hospital Anxiety and Depression Scale-HADS) ve Pittsburgh Uyku Kalite İndeksi (Pittsburgh Sleep Quality Index-PSQI) yüz yüze uygulandı. Çalışmaya alınan katılımcıların; anksiyete, depresyon, düşme ve PUKİ ölçeğinden alınan puanlarda deney ve kontrol grupları arasında istatistiksel olarak anlamlı farklılık bulunmuştur (p<0,05). Kontrol grubunda yer alanların; anksiyete, depresyon, düşme ve PUKİ ölçek puanlarının deney grubuna göre düşük olduğu tespit edilmiştir. Kliniğe başvuran vertigolu hastalar bu açıdan değerlendirilmeli ve klinisyenler hastaların psikolojik destek almaları açısından dikkatli olmalıdır.

Anahtar Kelimeler

COVID-19, SARS-CoV-2, Vertigo

SUBJECTIVE EVALUATION OF CORONAVIRUS 2019 PATIENTS WITH AND WITHOUT VERTIGO

Öz

The purpose of the present study is to compare individuals with and without vertigo who have experienced COVID-19 in terms of their psychological, emotional, sleep quality, and concerns about the possibility of falls. A total of 30 individuals were included in the study, including the case group with 15 subjects who were diagnosed with vertigo with past COVID-19, and the control group with 15 subjects who had past COVID-19 and were not diagnosed with vertigo. The Falls Efficacy Scale-International (FES-I), Hospital Anxiety and Depression Scale (HADS), and Pittsburgh Sleep Quality Index (PSQI) were applied face-to-face to the individuals who were included in the research. Among the participants’, who were included in the study; statistically significant differences in anxiety, depression, falls, and PUKI scores have been detected between the experimental and control groups (p<0.05). Of those in the control group; anxiety, depression, falls and PUKI scale scores have been found to be lower than the experimental group. Patients with vertigo who apply to the clinic must be evaluated in this respect, and clinicians must be careful in terms of the patients to receive psychological support.

Anahtar Kelimeler

COVID-19, SARS-CoV-2, Vertigo

Kaynakça

• Agargun, M. Y., Kara, H. & Anlar, Ö. (1996). Validity and reliability of the pittsburgh sleep quality index in Turkish sample. Turkish Journal of Psychiatry, 7, 107–115.
• Ahmad, I. & Rathore, F. A. (2020). Neurological manifestations and complications of COVID-19: A literature review. Journal of Clinical Neuroscience, 77, 8-12.
• Alhazzani, W., Evans, L., Alshamsi, F., Møller, M. H., Ostermann, M., Prescott, H. C., ...Fan, E. (2021). Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: First update. Critical care medicine, 49(3), e219-e234.
• Alpar, R. (2020). Uygulamalı istatistik ve geçerlik-güvenirlik (p. 333-336). Ankara: Detay Yayıncılık.
• Altena, E., Baglioni, C., Espie, C. A., Ellis, J., Gavriloff, D., Holzinger, B., ...Riemann, D. (2020). Dealing with sleep problems during home confinement due to the COVID‐19 outbreak: Practical recommendations from a task force of the European CBT‐I Academy. Journal of sleep research, 29(4), e13052.
• Aydemir, Ö., Guveni, T., Kuey, L. & Kultur, S. (1997). Validity and reliability of Turkish version of hospital anxiety and depression scale. Turk Psikiyatri Dergisi, 8(4),280-287.
• Baig, A. M., Khaleeq, A., Ali, U. & Syeda, H. (2020). Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS chemical neuroscience, 11(7), 995-998.
• Batra, P. S., LoSavio, P. S., Michaelides, E., Revenaugh, P. C., Tajudeen, B. A., Al-Khudari, S., ...Stenson, K. M. (2020). <? covid19?> Management of the clinical and academic mission in an urban otolaryngology department during the COVID-19 global crisis. Otolaryngology–Head and Neck Surgery, 163(1), 162-169.
• Buysse, D. J., Reynolds III C.F., Monk, T. H., Berman, S. R. & Kupfer, D. J. (1989). The pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Research, 28, 193-213.
• Gamaldo, C. E., Shaikh, A. K. & McArthur, J. C. (2012). The sleep-immunity relationship. Neurologic clinics, 30(4), 1313-1343.
• Korkmaz, M. Ö., Eğilmez, O. K., Özçelik, M. A. & Güven, M. (2021). Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. European Archives of Oto-Rhino-Laryngology, 278(5), 1675-1685.
• Lee, S. H., Shin, H.-S., Park, H. Y., Kim, J. L., Lee, J. J., Lee, H. & Han, W. (2019). Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in Middle East respiratory syndrome survivors. Psychiatry investigation, 16(1), 59.
• Liu, D., Baumeister, R. F., Veilleux, J. C., Chen, C., Liu, W., Yue, Y. & Zhang, S. (2020). Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan, China. Psychiatry Research, 292, 113297.
• Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., ...Wang, D. (2020). Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurology, 77(6), 683-690.
• Mazza, M. G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., ...Rovere-Querini, P. (2020). Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain, Behavior, and Immunity, 89, 594-600.
• Moriguchi, T., Harii, N., Goto, J., Harada, D., Sugawara, H., Takamino, J., ...Myose, N. (2020). A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. International Journal of Infectious Diseases, 94, 55-58.
• Niazkar, H. R., Zibaee, B., Nasimi, A. & Bahri, N. (2020). The neurological manifestations of COVID-19: A review article. Neurological Sciences, 41, 1667-1671.
• Poyraz, B. Ç., Poyraz, C. A., Olgun, Y., Gürel, Ö., Alkan, S., Özdemir, Y. E., ...Karaali, R. (2021). Psychiatric morbidity and protracted symptoms after COVID-19. Psychiatry Research, 295, 113604.
• Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., ...David, A. S. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet Psychiatry, 7(7), 611-627.
• Román, G. C., Spencer, P. S., Reis, J., Buguet, A., Faris, M. E. A., Katrak, S. M., ...Mizusawa, H. (2020). The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. Journal of the neurological sciences, 414, 116884.
• Sriwijitalai, W. & Wiwanitkit, V. (2020). Hearing loss and COVID-19: A note. American Journal of Otolaryngology. 41 (3), 102473.
• Tan, M., Cengiz, D. U., Demir, İ., Demirel, S., Çolak, S. C., Karakaş, O. & Bayındır, T. (2022). Effects of Covid-19 on the audio-vestibular system. American Journal of Otolaryngology, 43(1), 103173.
• Tomasoni, D., Bai, F., Castoldi, R., Barbanotti, D., Falcinella, C., Mulè, G., …Marchetti, G. (2021). Anxiety and depression symptoms after virological clearance of COVID‐19: a cross‐sectional study in Milan, Italy. Journal of Medical Virology, 93(2), 1175-1179.
• Ulus, Y., Durmus, D., Akyol, Y., Terzi, Y., Bilgici, A. & Kuru, O. (2012). Reliability and validity of the Turkish version of the Falls Efficacy Scale International (FES-I) in community-dwelling older persons. Archives of Gerontology and Geriatrics, 54(3), 429-433.
• Vaira, L. A., Salzano, G., Deiana, G. & De Riu, G. (2020). Anosmia and ageusia: common findings in COVID‐19 patients. The Laryngoscope, 130(7), 1787-1787.
• Van Reeth, O., Weibel, L., Spiegel, K., Leproult, R., Dugovic, C. & Maccari, S. (2000). Physiology of sleep (review)–interactions between stress and sleep: from basic research to clinical situations. Sleep Medicine Reviews, 4(2), 201-219.
• Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., ...Xiong, Y. (2020). Clinical features and treatment of COVID‐19 patients in northeast Chongqing. Journal of Medical Virology, 92(7), 797-806.
• Wong, J. E., Leo, Y. S. & Tan, C. C. (2020). COVID-19 in Singapore—current experience: Critical global issues that require attention and action. Jama, 323(13), 1243-1244.
• Wu, K. K., Chan, S. K. & Ma, T. M. (2005). Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS). Journal of Traumatic Stress: Official Publication of The International Society for Traumatic Stress Studies, 18(1), 39-42.
• Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., ...Yang, C. (2020). Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, Behavior, and Immunity, 87, 18-22.
• Xiao, H., Zhang, Y., Kong, D., Li, S. & Yang, N. (2020). Social capital and sleep quality in individuals who self-isolated for 14 days during the coronavirus disease 2019 (COVID-19) outbreak in January 2020 in China. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 26, e923921-923921.
• Xue, Z., Lin, L., Zhang, S., Gong, J., Liu, J. & Lu, J. (2020). Sleep problems and medical isolation during the SARS-CoV-2 outbreak. Sleep medicine, 70, 112.
• Yardley, L., Beyer, N., Hauer, K., Kempen, G., Piot-Ziegler, C. & Todd, C. (2005). Development and initial validation of the falls efficacy scale international (FES-I). Age and Ageing, 34, 614–619.
• Zigmond, A. S. & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361-370.